Hudson Bay Capital Management
OLMA icon

Hudson Bay Capital Management’s Olema Pharmaceuticals OLMA Stock Holding History

Hudson Bay Capital Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.31M Buy
+154,770
New +$3.45M 0.01% 734
2024
Q2 		– Sell
-67,507
Closed -$764K – 895
2024
Q1 		$764K Buy
67,507
+5,007
+8% +$64.6K ﹤0.01% 562
2023
Q4 		$877K Buy
+62,500
New +$840K 0.01% 530

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Hudson Bay Capital Management's OLMA Position: Q1 2026 in Review

Hudson Bay Capital Management opened a new position in Olema Pharmaceuticals (OLMA) in Q1 2026: 154,770 shares worth $2.31M. The stake represents 0.01% of the portfolio and ranks #734 among its holdings. This is a return to the name: Hudson Bay Capital Management previously reported a position in OLMA as recently as Q1 2024.

Hudson Bay Capital Management first reported a position in OLMA in Q4 2023 and has held it in 3 quarters since. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Hudson Bay Capital Management held 154,770 shares of Olema Pharmaceuticals worth $2.31M as of Q1 2026.
  • Olema Pharmaceuticals was a new Hudson Bay Capital Management position in Q1 2026.
  • Olema Pharmaceuticals made up 0.01% of Hudson Bay Capital Management's portfolio in Q1 2026, its #734 holding.
  • Hudson Bay Capital Management first reported a position in Olema Pharmaceuticals in Q4 2023 and has held it in 3 quarters since.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Hudson Bay Capital Management's 13F filing for Q1 2026, filed 13 May 2026.